Baxter International Inc. announced that on January 4, 2023, Giuseppe Accogli, the Executive Vice President and Chief Operating Officer of the company, resigned as Executive Vice President and Chief Operating Officer of the Company effective immediately and no longer serves as an executive officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.25 USD | +0.23% | -1.23% | -8.82% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.82% | 17.96B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Baxter International Inc. Announces Resignation of Giuseppe Accogli as Executive Vice President and Chief Operating Officer